Gabapentin Tablet
Product Images NDC 63629-7307

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-7307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1

FDA Label Image

Figure2

Figure2
This appears to be a table or graph related to pain management, with columns for different dosage periods and rows for pain score data. It is not possible to derive a meaningful description without additional context or information.*
FDA Label Image

Figure3

Figure3
The given text is describing a graph that shows the percentage of patients who responded to a pain reduction treatment at the endpoint of two studies on PHN (Postherpetic neuralgia). The graph shows the percentage of patients who experienced a 2-50% reduction in pain score. The studies had two treatment groups with varying dosages of GBP (Gabapentin). The graph also includes asterisks indicating significant differences in the treatments.*
FDA Label Image

Figure4

FDA Label Image
FDA Label Image

Structure.jpg (Structure)

FDA Label Image

Equation.jpg (Equation)

FDA Label Image

Label Image (Lbl636297307)

Label Image (Lbl636297307)
This is a packaging label for Neurontin 600mg tablets from Glenmark Pharmaceuticals Ltd. The label includes the expiration date and NDC number for the medication. It also notes the storage temperature range and includes a warning to keep the medication out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.